4//SEC Filing
Huggenberger Raymond 4
Accession 0001209191-21-041522
CIK 0001294133other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:09 PM ET
Size
10.9 KB
Accession
0001209191-21-041522
Insider Transaction Report
Form 4
Inogen IncINGN
Huggenberger Raymond
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-06-15$38.54/sh+4,000$154,160→ 27,670 total - Sale
Common Stock
2021-06-15$63.87/sh−4,000$255,462→ 23,670 total - Sale
Common Stock
2021-06-15$63.73/sh−3,087$196,750→ 20,583 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−4,000→ 23,806 totalExercise: $38.54Exp: 2022-05-15→ Common Stock (4,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- [F2]Represents the weighted average share price of an aggregate total of 4,000 shares sold in the price range of $63.28 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 3,087 shares sold in the price range of $63.11 to $64.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The previously filed Form 4 on January 16, 2019 listed an incorrect number.
Documents
Issuer
Inogen Inc
CIK 0001294133
Entity typeother
Related Parties
1- filerCIK 0001596078
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:09 PM ET
- Size
- 10.9 KB